Recently, it has been found that CUMS-induced NE release can decrease the polarization of AQP4 expression in astrocytes, inhibiting the function of the glymphatic system and inducing oxidative stress and inflammation, leading to depression-like symptoms [51]. Here, AQP4 is linked to major depressive disorder.